SGLT2 inhibition improves coronary flow velocity reserve and contractility: role of glucagon signaling.
Göpel SO, Adingupu D, Wang J, Semenova E, Behrendt M, Jansson-Löfmark R, Ahlström C, Jönsson-Rylander AC, Gopaul VS, Esterline R, Gan LM, Xiao RP.
Göpel SO, et al. Among authors: ahlstrom c.
Cardiovasc Diabetol. 2024 Nov 15;23(1):408. doi: 10.1186/s12933-024-02491-w.
Cardiovasc Diabetol. 2024.
PMID: 39548491
Free PMC article.